High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays:: application to chondrosarcoma

被引:82
作者
Baelde, HJ
Cleton-Jansen, AM
van Beerendonk, H
Namba, M
Bovée, JVMG
Hogendoorn, PCW
机构
[1] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands
[2] Okayama Univ, Sch Med, Inst Mol & Cellular Biol, Dept Cell Biol, Shikata, Japan
关键词
RNA extraction; cartilage; bone neoplasm; chondrosarcoma; cDNA microarray; expression profile;
D O I
10.1136/jcp.54.10.778
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
Aims-High quality RNA isolation from cartilaginous tissue is considered difficult because of relatively low cellularity and the abundance of extracellular matrix rich in glycosaminoglycans and collagens. Given the growing interest and technical possibilities to study RNA expression at a high throughput level, research on tissue with these characteristics is hampered by the lack of an efficient method for obtaining sufficient amounts of high quality RNA. Methods-This paper presents a robust protocol combining two RNA isolation procedures, based on a combination of Trizol and RNA specific columns, which has been developed to obtain high molecular weight RNA from fresh frozen and stored tissue of normal cartilage and cartilaginous tumours. Using this method, RNA was isolated from normal cartilage, peripheral chondrosarcoma, and central chondrosarcoma. Results-The yields ranged from 0.1 to 0.5 mug RNA/mg tissue. RNA isolated with this method was stable and of high molecular weight. RNA samples from normal cartilage and from two chondrosarcomas isolated using this method were applied successfully in cDNA microarray experiments. The number of genes that give interpretable results was in the range of what would be expected from microarray results obtained on chondrosarcoma cell line RNA. Signal to noise ratios were good and differential expression between tumour and normal cartilage was detectable for a large number of genes. Conclusion-With this newly developed isolation method, high quality RNA can be obtained from low cellular tissue with a high extracellular matrix component. These procedures can also be applied to other tumour material.
引用
收藏
页码:778 / 782
页数:5
相关论文
共 14 条
[1]
Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations [J].
Bernard, MA ;
Hogue, DA ;
Cole, WG ;
Sanford, T ;
Snuggs, MB ;
Montufar-Solis, D ;
Duke, PJ ;
Carson, DD ;
Scott, A ;
Van Winkle, WB ;
Hecht, JT .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (03) :442-450
[2]
Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma [J].
Bovée, JVMG ;
van Royen, M ;
Bardoel, AFJ ;
Rosenberg, C ;
Cornelisse, CJ ;
Cleton-Jansen, AM ;
Hogendoorn, PCW .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (05) :1587-1595
[3]
Bovée JVMG, 1999, GENE CHROMOSOME CANC, V26, P237
[4]
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas [J].
Bovée, JVMG ;
Cleton-Jansen, AM ;
Wuyts, W ;
Caethoven, G ;
Taminiau, AHM ;
Bakker, E ;
Van Hul, W ;
Cornelisse, CJ ;
Hogendoorn, PCW .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (03) :689-698
[5]
Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma [J].
Bovée, JVMG ;
van den Broek, LJCM ;
Cleton-Jansen, AM ;
Hogendoorn, PCW .
LABORATORY INVESTIGATION, 2000, 80 (12) :1925-1934
[6]
DeRisi J, 1996, NAT GENET, V14, P457
[7]
Kunisada T, 1998, INT J CANCER, V77, P854, DOI 10.1002/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO
[8]
2-1
[9]
EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses [J].
Legeai-Mallet, L ;
Rossi, A ;
Benoist-Lasselin, C ;
Piazza, R ;
Malet, JF ;
Delezoide, AL ;
Munnich, A ;
Bonaventure, J ;
Zylberberg, L .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (08) :1489-1500
[10]
New perspectives on the molecular basis of hereditary bone tumours [J].
McCormick, C ;
Duncan, G ;
Tufaro, F .
MOLECULAR MEDICINE TODAY, 1999, 5 (11) :481-486